Sodium valproate in trigeminal neuralgia

Area of Science:

• Neurology
• Pharmacology

Background:

• Trigeminal neuralgia is a debilitating neuropathic pain condition.
• Limited effective long-term treatments exist for trigeminal neuralgia.

Purpose of the Study:

• To evaluate the efficacy of sodium valproate in patients with trigeminal neuralgia.

Main Methods:

• Twenty patients diagnosed with trigeminal neuralgia were administered sodium valproate.
• Treatment outcomes, including attack frequency, severity, and patient tolerance, were monitored.

Main Results:

• Six out of 20 patients (30%) experienced no trigeminal neuralgia attacks for 6-18 months.
• Three patients (15%) reported at least a 50% reduction in attack frequency and severity.
• Four patients (20%) showed good response when sodium valproate was combined with other medications.
• Six patients (30%) had minimal or no response to sodium valproate.
• One patient (5%) exhibited poor tolerance to the medication.

Conclusions:

• Sodium valproate demonstrates potential as an effective treatment for trigeminal neuralgia, offering significant pain relief for a subset of patients.
• Combination therapy with sodium valproate may enhance treatment outcomes for some individuals.
• Further research is warranted to optimize its use and identify patient subgroups most likely to benefit.